抗结核治疗的内镜与临床反应可区分肠结核与克罗恩病
本研究通过回顾性比较(288例)和前瞻性验证(55例)评估抗结核治疗试验在肠结核与克罗恩病鉴别中的作用。结果显示,克罗恩病患者抗结核治疗后黏膜愈合率极低(5% vs 肠结核100%),而症状反应率较高;肠结核患者症状反应和黏膜愈合均良好。结论提示,6个月抗结核治疗后症状反应但黏膜未愈合需重复结肠镜诊断克罗恩病,治疗3个月后症状持续可能提示克罗恩病。
要点
- 克罗恩病患者抗结核治疗后黏膜愈合率仅5%,肠结核患者为100%。
- 肠结核患者抗结核治疗3个月内症状反应率达94%。
- 抗结核治疗6个月后症状反应但黏膜未愈合需重复结肠镜诊断克罗恩病。
核心结论
- 克罗恩病患者抗结核治疗6个月后症状反应率较高但黏膜愈合率极低,提示需重复结肠镜以诊断克罗恩病。
- 肠结核患者抗结核治疗2-3个月后症状显著反应,若治疗3个月后症状持续可能提示克罗恩病诊断。
研究设计与样本
- 回顾性比较研究纳入288例患者,其中131例在诊断为克罗恩病前接受过抗结核治疗,157例为肠结核患者。
- 前瞻性验证研究纳入55例肠结核与克罗恩病诊断存疑的患者。
主要发现
- 在推导队列中,最终诊断为克罗恩病的患者抗结核治疗3个月时总体症状反应率为38%,完成6个月治疗者中为37%;肠结核患者3个月内总体症状反应率为94%。
- 克罗恩病患者内镜下黏膜愈合率仅5%,而肠结核患者为100%。
- 在验证队列中,所有肠结核患者抗结核治疗6个月后均出现症状反应和内镜下黏膜愈合。
- 最终诊断为克罗恩病的患者中,抗结核治疗2个月时症状反应率为64%,完成6个月治疗者中为31%,无一例黏膜愈合。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Differentiation between intestinal tuberculosis and Crohn's disease is difficult and may require therapeutic trial with anti-tubercular therapy in tuberculosis-endemic regions. AIM: To evaluate the role of therapeutic trial with anti-tubercular therapy in patients with diagnostic confusion between intestinal tuberculosis and Crohn's disease. METHODS: We performed retrospective-comparative (n = 288: 131 patients who received anti-tubercular therapy before being diagnosed as Crohn's disease and 157 intestinal tuberculosis patients) and prospective-validation study (n = 55 patients with diagnostic confusion of intestinal tuberculosis/Crohn's disease). Outcomes assessed were global symptomatic response and endoscopic mucosal healing. RESULTS: In the derivation cohort, among those eventually diagnosed as Crohn's disease, global symptomatic response with anti-tubercular therapy was seen in 38% at 3 months and in 37% who completed 6 months of anti-tubercular therapy. Ninety-four per cent of intestinal tuberculosis patients showed global symptomatic response by 3 months. Endoscopic mucosal healing was seen in only 5% of patients with Crohn's disease compared with 100% of intestinal tuberculosis patients. In the validation cohort, all the patients with intestinal tuberculosis had symptomatic response and endoscopic mucosal healing after 6 months of anti-tubercular therapy. Among the patients with an eventual diagnosis of Crohn's disease, symptomatic response was seen in 64% at 2 months and in 31% who completed 6 months of anti-tubercular therapy, none had mucosal healing. CONCLUSIONS: Disproportionately lower mucosal healing rate despite an overall symptom response with 6 months of anti-tubercular therapy in patients with Crohn's disease suggests a need for repeat colonoscopy for diagnosing Crohn's disease. Patients with intestinal tuberculosis showing significant symptomatic response after 2-3 months of anti-tubercular therapy, suggest that symptom persistence after a therapeutic trial of 3 months of anti-tubercular therapy may indicate the diagnosis of Crohn's disease.
引用
- Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther. 2016. PMID: 27813111. doi:10.1111/apt.13840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。